Inhibitory receptors and their modes of action.
Fong
D C
DC
Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, and Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado 80206, USA.
Cambier
J C
JC
D000818:Animals; D018941:Antigens, CD19 / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism; D051379:Mice; D000072183:Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism; D017452:Receptors, IgG / Q000378:metabolism; D011971:Receptors, Immunologic / Q000378:metabolism*; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism
D018941:Antigens, CD19; D002352:Carrier Proteins; D011947:Receptors, Antigen, B-Cell; D017452:Receptors, IgG; D011971:Receptors, Immunologic; D010744:Phosphoric Monoester Hydrolases; C098706:INPPL1 protein, human; D000072183:Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases